In its response to the NIH’s Strengthening and Modernizing Biosafety Oversight Initiative, COGR emphasizes the need for biosafety policies that are science-based...
Biosafety & Related Research Issues
Issues and requirements associated with research involving certain biological agents and toxins (e.g., elect agents, recombinant and synthetic nucleic acid molecules, dual-use research of concern (DURC)) that pose significant safety and/or public health risks and require additional agency or institutional review and oversight.
Featured
COGR Submits Letter to EPA on NPRM Regarding Methylene Chloride; Regulation Under the Toxic Substances Control Act; Compliance Date Extensions
COGR, representing over 230 U.S. research institutions, submitted comments to the EPA regarding compliance date extensions for regulations on methylene chloride...
COGR, ABSA, and ASM Request Clarification on DURC/PEPP Policy March 25, 2025
Representatives of the American Society for Microbiology, the Association for Biosafety and Biosecurity International, and COGR are requesting a meeting with NIH...
Resources
Point of Contact
Kristin West
Director, Research Ethics & Compliance
All Biosafety & Related Research Issues Articles
COGR Responds to RFI on Potential Changes to the Policies for Oversight of Dual Use Research of Concern (DURC) and the Potential Pandemic Pathogen Care and Oversight (P3CO) Policy Framework
The Council on Governmental Relations (COGR), representing over 200 U.S. research universities and related institutions, submitted detailed comments to the Office of Science and Technology Policy (OSTP) regarding proposed changes to the oversight policies for Dual Use Research of Concern (DURC) and Potential Pandemic Pathogen Care and Oversight (P3CO). While COGR emphasizes its strong commitment t
COGR Responds to Proposed Amendments to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) (88 FR 54332)
The Council on Governmental Relations (COGR), representing over 200 U.S. research universities and affiliated institutions, submitted comments to the National Institutes of Health (NIH) regarding proposed amendments to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. COGR supports the NIH's efforts to enhance safety and align its guidelines with the C
COGR Submits Comments on NIH Guidelines on Recombinant or Synthetic Nucleic Acid Molecules
COGR responded to the National Institutes of Health’s (NIH) request for public comments regarding proposed amendments to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. COGR expresses support for the NIH’s intention to optimize the benefit of the Recombinant DNA Advisory Committee (RAC) review process by restricting detailed gene transfer reviews to excep
